More than half of breast cancer patients develop diastolic dysfunction after anthracy

[News]

Patients who undergo treatment with anthracycline-based chemotherapy for breast cancer are at risk of developing diastolic dysfunction, according to a new study published in The Oncologist.

More... (http://www.medicalnewstoday.com/releases/296978.php)